Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cell Source, Inc.CLCS · Entity 9600 | Director · 10% owner | August 09, 2021 | August 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cell Source, Inc.
Report date August 09, 2021 · Filed August 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrant (Option to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2026-06-18 | Direct | 800,000 |
Reported balance
After 2021-08-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-08-09 · Other · Acquired 800,000 · Balance 800,000 F1: Issued in connection with funding of convertible note. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued in connection with funding of convertible note.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2021 Filed Aug 11, 2021 15:00 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherWarrant (Option to buy) · Derivative | 800,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001493152-21-019296 · ownership.xml · derivative · entry 1 Soave Darlene · CIK 0001856892 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2026-06-18 F1 · kind: Issued in connection with funding of convertible note. Read SEC document |
| June 30, 2021 Filed Jul 7, 2021 16:54 UTC | Cell Source, Inc. CLCS · Entity 9600 | OtherCommon Stock | 59,507 | $0.75 | $44,630.25 |
DisclosureSEC source: 0001493152-21-016322 · ownership.xml · nonDerivative · entry 1 Soave Darlene · CIK 0001856892 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,434 F1 · kind: Issued as payment-in-kind dividend on Series A Convertible Preferred Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.